Lloyd G Price
Lloyd G Price is a Partner and Co‑Founder of Nelson Advisors, a specialist HealthTech M&A advisory firm, and one of the most recognised entrepreneurial figures in UK and European digital health. Drawing on over 25 years of experience across consumer internet and healthcare technology, he now sits at the intersection of HealthTech mergers and acquisitions, strategic partnerships and investment strategy, advising founders, boards and investors on when to build, buy, partner or sell.
Price co‑founded Nelson Advisors with fellow entrepreneur and dealmaker Paul Hemings to create a boutique advisory house focused exclusively on Healthcare Technology. The firm’s “Build, Buy, Partner, Sell” framework reflects his conviction that value creation in HealthTech demands more than one‑off transactions, instead requiring long‑term corporate development planning around organic growth, acquisitions, alliances and exits. Nelson Advisors concentrates on Digital Health, Health IT, Consumer Health, Healthcare AI and cybersecurity, positioning Price at the centre of a pan‑European and transatlantic deal network spanning strategics, financial sponsors and high‑growth scale‑ups.
Before founding Nelson Advisors, Price spent over a decade as a HealthTech entrepreneur, most notably as Co‑Founder and CRO of Zesty, a digital patient engagement and appointment platform launched in 2012. Under his leadership, Zesty grew into one of Europe’s leading digital health companies, winning more than 60 industry awards and raising over 10 million dollars from top-tier US and European venture funds before its acquisition by FTSE‑listed Induction Healthcare Group in 2020. Zesty’s inclusion in the UK Government’s Digital Health Playbook “First 100” companies and multiple NHSX digital playbook case studies further underlined both the platform’s impact and Price’s ability to scale innovation within complex public healthcare systems.
Price’s entrepreneurial portfolio extends beyond a single exit. Together with his Nelson Advisors co‑founder, he has helped build, scale and exit four HealthTech ventures across patient engagement, medical device cybersecurity, metabolic health and consumer healthcare, securing buyers ranging from North American and European strategics to FTSE‑listed acquirers. This practitioner-led background—“HealthTech entrepreneurs advising HealthTech entrepreneurs”—is central to his advisory positioning and informs his approach to valuation, due diligence and post‑merger integration.
Before moving into HealthTech, Price held senior business development, marketing, strategy and corporate development roles at leading consumer internet companies including Kelkoo, Yahoo! UK, Yahoo! Europe and Badoo between 2000 and 2012. These roles exposed him early to data‑driven growth, online marketplaces and consumer engagement models, capabilities he later translated into healthcare, where he is known for linking engagement metrics and cohort performance to enterprise value and transaction structures. His early career includes being among the first dozen UK employees at Kelkoo, giving him first‑hand experience of scaling a venture-backed internet company through rapid growth and strategic exits.
Beyond deal execution, Price is a regular commentator and press source on HealthTech funding, exits and AI‑driven transformation of care delivery, with interviews and insights featured in sector publications such as HSJ, Digital Health, Mergermarket, Healthcare Business International and Future Health Intelligence. A recent podcast described him as “one of the UK’s most respected HealthTech entrepreneurs and advisors,” capturing his dual identity as both operator and banker. In these forums he frequently emphasises disciplined growth, repeatable commercial models and realistic M&A‑led exit pathways as critical success factors for European founders.
His visibility in the ecosystem is reinforced by extensive speaking and chairing engagements. Price has delivered talks and moderated sessions for organisations such as McKinsey, Citi, The Economist and the European Parliament, as well as major sector events including Digital Health Rewired and other flagship UK and European HealthTech conferences. He is also the founder of The Future Health community, launched in 2024 as a platform to connect innovators, investors and healthcare leaders around the next generation of digital and AI‑enabled care models.
Price is in regular demand as an awards judge, reflecting his standing as a curator of the most promising HealthTech and MedTech companies. He has served multiple times on the judging panel for the Digital Health PitchFest Awards, including Rewired 2026, helping surface and evaluate high‑potential startups bringing new digital solutions into the NHS. In 2024 he was invited to judge the HealthInvestor Power List Awards, recognising the most effective and influential leaders in health and social care, and continues to contribute to subsequent editions of the Power List.
Academia and talent development are another pillar of Price’s profile. He advises and mentors students and early-stage founders at top universities including Oxford University, University College London, Cambridge Judge Business School and London Business School, where he has contributed to programmes at the intersection of HealthTech, entrepreneurship and finance. His own formal training includes executive education in corporate finance at London Business School, complementing his practitioner experience with structured deal-making and valuation expertise. In parallel, he actively engages with European business schools on HealthTech-focused events, case discussions and mentoring, encouraging institutions to sharpen their focus on digital health and AI as core components of modern management education.
In governance roles, Price serves as a Non‑Executive Director and board member for several UK HealthTech and Digital Health businesses, including leading MSK self‑care platform getUbetter and urgent care workforce management provider Doc Abode. These companies have secured prestigious awards and accelerator places—from HSJ categories to the AWS Healthcare Accelerator—which further underscores the quality of the ventures to which he lends his strategic oversight. Through these NED and advisory mandates, he supports management teams on go‑to‑market, fundraising, partnership strategy and exit readiness, reinforcing his reputation as a trusted board‑level voice.
Across all of these activities, Price’s biography is defined by a consistent thread: translating first‑hand entrepreneurial experience into high‑impact advisory work for the next generation of HealthTech leaders. Whether in the boardroom, on stage, in the classroom or on awards juries, he combines commercial rigour with a strong ecosystem mindset, helping to shape both the deal landscape and the broader talent pipeline that underpins European digital health and MedTech.